tradingkey.logo

GeneDx Holdings Corp

WGS
查看详细走势图
130.060USD
+2.060+1.61%
收盘 12/31, 16:00美东报价延迟15分钟
3.76B总市值
1198.49市盈率 TTM

GeneDx Holdings Corp

130.060
+2.060+1.61%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.61%

5天

-4.43%

1月

-22.10%

6月

+40.89%

今年开始到现在

0.00%

1年

+69.22%

查看详细走势图

TradingKey GeneDx Holdings Corp股票评分

单位: USD 更新时间: 2025-12-31

操作建议

GeneDx Holdings Corp当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名33/78位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价160.89。中期看,股价处于平稳状态。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

GeneDx Holdings Corp评分

相关信息

行业排名
33 / 78
全市场排名
157 / 4560
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 9 位分析师
买入
评级
160.889
目标均价
+0.68%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

GeneDx Holdings Corp亮点

亮点风险
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
业绩高增长
公司营业收入稳步增长,连续3年增长30.15%
估值高估
公司最新PE估值1198.49,处于3年历史高位
机构减仓
最新机构持股32.52M股,环比减少2.75%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值103.20K
活跃度降低
近期活跃度降低,过去20天平均换手率0.10

GeneDx Holdings Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

GeneDx Holdings Corp简介

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
公司代码WGS
公司GeneDx Holdings Corp
CEOStueland (Katherine A)
网址https://sema4.com/

常见问题

GeneDx Holdings Corp(WGS)的当前股价是多少?

GeneDx Holdings Corp(WGS)的当前股价是 130.060。

GeneDx Holdings Corp的股票代码是什么?

GeneDx Holdings Corp的股票代码是WGS。

GeneDx Holdings Corp股票的52周最高点是多少?

GeneDx Holdings Corp股票的52周最高点是170.870。

GeneDx Holdings Corp股票的52周最低点是多少?

GeneDx Holdings Corp股票的52周最低点是55.170。

GeneDx Holdings Corp的市值是多少?

GeneDx Holdings Corp的市值是3.76B。

GeneDx Holdings Corp的净利润是多少?

GeneDx Holdings Corp的净利润为-52.29M。

现在GeneDx Holdings Corp(WGS)的股票是买入、持有还是卖出?

根据分析师评级,GeneDx Holdings Corp(WGS)的总体评级为买入,目标价格为160.889。

GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是多少

GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是0.109。
KeyAI